- Home
- NRDS vs OVID Comparison
NRDS vs OVID Comparison
Compare NRDS & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRDS | OVID |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | 650 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 629.0M | 522.6M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | NRDS | OVID |
|---|---|---|
| Price | $9.83 | $2.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $15.00 | $4.60 |
| AVG Volume (30 Days) | 693.4K | ★ 1.5M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 68.42 | 3.90 |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $836,600,000.00 | $7,252,000.00 |
| Revenue This Year | $10.13 | N/A |
| Revenue Next Year | $7.11 | $19.34 |
| P/E Ratio | $27.03 | ★ N/A |
| Revenue Growth | 21.67 | ★ 1181.27 |
| 52 Week Low | $7.33 | $0.84 |
| 52 Week High | $16.24 | $3.11 |
Technical Indicators
Market Signals| Indicator | NRDS | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 58.23 | 63.71 |
| Support Level | $9.36 | $2.22 |
| Resistance Level | $11.05 | $3.05 |
| Average True Range (ATR) | 0.40 | 0.15 |
| MACD | 0.07 | 0.04 |
| Stochastic Oscillator | 76.43 | 86.67 |
Price Performance
Historical ComparisonAbout NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. The Company's platform comprises three primary components: Editorial and Content Publishing, Marketplace and Referral Services, and Financial Services. It operates in the United States, Canada, and the United Kingdom.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.